You are here

MK-1602

Bowing out of a crowded race, Merck sells a migraine drug to Allergan for $250M

Fierce Biotech

Tue, 07/7/15 - 09:10 am

3 Companies Working to Make Migraines Milder

Motley Fool

Wed, 08/7/13 - 09:36 am

Arteaus Therapeutics

Alder Biopharmaceuticals

Bristol-Myers Squibb